Sort   by:  
 Page size 
UnknownThe recurrent SETBP1 c.2608G > A, p.(Gly870Ser) variant in a patient with Schinzel-Giedion syndrome: an illustrative case of the utility of whole exome sequencing in a critically ill neonate.
Not available
S-EPMC7254667 | biostudies-literature
UnknownCompassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
Not available
S-EPMC9105283 | biostudies-literature
UnknownLenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
Not available
S-EPMC3815174 | biostudies-literature
UnknownPosttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial.
Not available
S-EPMC12018986 | biostudies-literature
UnknownBusulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.
Not available
S-EPMC11339290 | biostudies-literature
UnknownAn Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.
Not available
S-EPMC12552284 | biostudies-literature
UnknownStem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial.
Not available
S-EPMC11266400 | biostudies-literature
UnknownNovel genetic variants of KHDC3L and other members of the subcortical maternal complex associated with Beckwith-Wiedemann syndrome or Pseudohypoparathyroidism 1B and multi-locus imprinting disturbances.
Not available
S-EPMC9148495 | biostudies-literature
UnknownClinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
Not available
S-EPMC11613624 | biostudies-literature
UnknownMyeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Not available
S-EPMC9200637 | biostudies-literature
Sort   by:  
 Page size